切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2011, Vol. 07 ›› Issue (02) : 92 -96. doi: 10.3877/cma.j.issn.1673-5250.2011.02.001

专家约稿

EB病毒感染相关性噬血细胞综合征的发病机制、诊断和治疗
李文益, 薛红漫   
  1. 510120 广东广州,中山大学孙逸仙纪念医院儿科
  • 出版日期:2011-04-01
  • 基金资助:
    广东省科技计划项目(2009B060700029)
  • Published:2011-04-01
引用本文:

李文益, 薛红漫. EB病毒感染相关性噬血细胞综合征的发病机制、诊断和治疗[J]. 中华妇幼临床医学杂志(电子版), 2011, 07(02): 92-96.

1 Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lympho-histiocytosis in Japan [J]. Int J Hematol, 2007, 86(1): 58-65.
2 The Cooperation Group of Hemaphagocytic syndrome in Guangdong Province. Clinical characteristics of 68 children with hemophagocytic syndrome [J]. J China Pediatr Blood Cancer, 2009, 14(1): 13-16. [广东省小儿噬血细胞综合征协作组. 小儿噬血细胞综合征68例临床研究[J]. 中国小儿血液与肿瘤杂志,2009, 14(1): 13-16.]
3 Kasahara Y, Yachie A. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection [J]. Crit Rev Oncol Hematol, 2002, 44(3): 283-294.
4 Wada T, Kurokawa T, Toma T, et al. Immunophenotypic analysis of Epstein-Barr virus (EBV)-infected CD8(+) T cells in a patient with EBV-associated hemophagocytic lymphohistiocytosis [J]. Eur J Haematol, 2007, 79(1): 72-75.
5 Lin MT, Chang HM, Huang CJ, et al. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis [J]. J Clin Pathol, 2007, 60(1): 101-103.
6 Toga A, Wada T, Sakakibara Y, et al. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis [J]. J Infect Dis, 2010, 201(12): 191923-191932.
7 Dupré L, Andolfi G, Tangye SG, et al. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells [J]. Blood, 2005, 105(11): 4383-4389.
8 Chuang HC, Lay JD, Chuang SE, et al. Epstein-Barr virus (EBV) latent membrane protein-1 down-regulates tumor necrosis factor-alpha (TNF-alpha) receptor-1 and confers resistance to TNF-alpha-induced apoptosis in T cells: Implication for the progression to T-cell lymphoma in EBV-associated hemophagocytic syndrome [J]. Am J Pathol, 2007, 170(5): 1607-1617.
9 Chuang HC, Lay JD, Hsieh WC, et al. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome [J]. Blood, 2005, 106(9): 3090-3096.
10 Blake N, Haigh T, Shaka'a G, et al. The importance of exogenous antigen in priming the human CD8+ T cell response: Lessons from the EBV nuclear antigen EBNA1 [J]. J Immunol, 2000, 165(12): 7078-7087.
11 Correa RM, Fellner MD, Alonio LV, et al. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene [J]. J Med Virol, 2004, 73(4): 583-588.
12 Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis [J]. Eur J Pediatr, 2007, 166 (2): 95-109.
13 Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2007, 48(2): 124-131.
14 Wang Z, Wang YN, Feng CC, et al.Diagnostic significance of NK cell activity and soluble CD25 level in serum from patients with secondary hemophagocytic lymphohistiocytosis [J]. J Exp Hematol, 2008,16(5): 1154-1157.[王昭,王旖旎,冯翠翠,等. NK细胞活性与血清可溶性CD25水平检测在继发性噬血细胞性淋巴组织细胞增多症诊断中的意义 [J]. 中国实验血液学杂志,2008,16(5): 1154-1157.]
15 Chung HJ, Park CJ, Lim JH, et al. Establishment of a reference interval for natural killer cell activity through flow cytometry and its clinical application in the diagnosis of hemophagocytic lymphohistiocytosis [J]. Int J Lab Hematol, 2010, 32(2): 239-247.
16 Lin TF, Ferlic-Stark LL, Allen CE, et al. Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality [J]. Pediatr Blood Cancer, 2011, 56(1): 154-155.
17 Gupta A, Tyrrell P, Valani R, et al. The role of the initial bone marrow aspirate in the diagnosis of hemophagocytic lymphohistiocytosis [J]. Pediatr Blood Cancer, 2008, 51(3): 402-404.
18 Wang Z, Chen X, Wu L, et al. Significance of hemophagocytosis in siagnosis of hemophagocytic lymphohistiocytosis [J]. J Exp Hematol, 2009, 17(4): 1064-1066.[王昭,陈皙,吴林,等. 噬血细胞现象在诊断噬血细胞性淋巴组织细胞增多症中意义的探讨 [J]. 中国实验血液学杂志,2009, 17(4): 1064-1066.]
19 Xue HM, Cen DY, Lin CY, et al. The role of hemophagocytosis in bone marrow in the diagnosis and treatment of hemophagocytic lymphohistiocytosis [J]. China Clin Pract Med, 2010,4(10): 87-88. [薛红漫,岑丹阳,林春燕,等. 探讨骨髓噬血细胞现象在儿童HLH诊治中的意义[J].中国临床实用医学杂志,2010,4(10):87-88.]
20 Nagasawa M, Yi Z, Imashuku S, et al. Soluble TWEAK is mar-kedly elevated in hemophagocytic lymphohistiocytosis [J]. Am J Hematol, 2008, 83(3): 222-225.
21 Kawa K. Hemophagocytic syndrome-treatment strategies according to classification and scoring system [C]. Education Program Book of the 67th Annual Meeting of the Japanese Society of Hematology and the 47th Annual Meeting of the Japanese Society of Clinical Hematology. Tokyo, Japan, 2005: 72-75
22 Imashuku S. Treatment of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis (EBV-HLH); update 2010 [J]. J Pediatr Hematol Oncol, 2011, 33(1): 35-39.
23 Xue HM, Cen DY, Xia Y, et al. Treatment of EBV-Hemophagocytic lymphohistiocytosis with hemophagocytic lymphohistiocytosis-04 protocol [J/CD]. Chin J Obstet Gynecol Pediatr, 2009,5(3):56-59. [薛红漫,岑丹阳,夏焱,等.噬血细胞综合征-04方案治疗小儿EB病毒相关性噬血细胞综合征[J/CD]. 中华妇幼临床医学杂志:电子版,2009,5(3):56-59.]
24 Balamuth NJ, Nichols KE, Paessler M, et al. Use od rituximab in conjunction with immuno-suppressive chemotherapy as a novel therapy for epstein-barr virus-associated hemophagocytic lymphohistiocytosis [J]. J Pediatr Hematol Oncol, 2007, 29(8): 569-573.
25 Celkan T, Alhaj S, Civilibal M, et al. Control of bleeding associated with hemophagocytic syndrome in children: An audit of the clinical use of recombinant activated factor Ⅶ [J]. Pediatr Hematol, 2007, 24(2): 117-121.
26 Sato E, Ohga S, Kuroda H, et al. Allogeneic hematopoietic stem cell transplantation for epstein-barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan [J]. Am J Hematol, 2008, 83(9): 721-727.
27 Ouachee-Chardin M, Elie C, de Saint Basile G, et al. Hemotopoietic stem cell transplantation in hemophagocytic lymphohistiocutosis: A single-center report of 48 patiens [J]. Pediatrics, 2006, 117(4): e743-750.
28 Cesaro S, LOcatelli F, Lanino E, et al. Hemotopoietic stemcell transplantation for hemophagocytic lymphohistiocutosis: A retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP) [J]. Haematologica, 2008, 93(11): 1694-1701.
No related articles found!
阅读次数
全文


摘要